Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Released Aug 9, 2019, during market hours
10-Q filed Aug 9, 2019, 40 days after period end · 0001144204-19-038714
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $205.99K | $0.00 | — |
| Net Income | -$5.57M | -$4.81M | -$1.89M | $5.97M |
| EPS Diluted |
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
| -$0.12 |
| -$0.41 |
| -$0.22 |
| $0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
